Archive for September, 2012

Royalty Financing Dealmaking in Biopharma Industry Discussed in New…

New research report “Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics” elaborated by CurrentPartnering has been recently published by Market Publishers Ltd.(PRWeb September 03, 2012)Read the full story at http://www.prwe…


Royalty Financing Dealmaking in Biopharma Industry Discussed in New…

New research report “Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics” elaborated by CurrentPartnering has been recently published by Market Publishers Ltd.(PRWeb September 03, 2012)Read the full story at http://www.prwe…


New From OSIMPLANT: First Of Its Kind ARAMIS Cervical Disc Prosthesis

Revolutionary Cervical Disc Design Incorporates MOTIS® High Performance Polymer to Reduce Wear Rate & Extend Service Life(PRWeb September 03, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9852994.htm


Quit Smoking: Free Electronic Cigarette Giveaway Announced by…

E cigarette seems to grow in popularity as more and more positive study results are given away to the public. In support of this,…(PRWeb September 02, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9861751.htm


Drug Patent Expirations for Aug 14 2012

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations

Journal of Commercial Biotechnology

ADVERTISE
HERE

This
newsletter is a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents


Simple flat-rate database subscription
plans

Ultimate
Plan
Premium Plan Basic Plan
One year $1,995 Subscribe $1,795 Subscribe $1,095 Subscribe
One month $525 Subscribe $425 Subscribe $325 Subscribe
48 hours $95 Subscribe $75 Subscribe
Free
Trial
    Plan
comparison
    Site
tour
    Discount
schedule
    Contact






Drug Patent Expirations for August 14 2012

Tradename Applicant Generic Name Patent
Expiration
EXELON Novartis rivastigmine Aug 14, 2012
EXELON Novartis rivastigmine tartrate Aug 14, 2012

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.








DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details


DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.

Continue reading

NSG Precision Cells Opens the Spigot with its New Line of Water…

NSG Precision Cells, world leader in the spectroscopy industry, is proud to announce they launched their exclusive…(PRWeb September 02, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9858758.htm


In-Pipe Technology Awarded Contract for Green Sewer Collection System…

In-Pipe Technology’s Agent in Mexico awarded a contract to implement In-Pipe’s green sewer collection system treatment to improve effluent quality and increase treatment capacity at the Services of…(PRWeb September 02, 2012)Read the full story…


Drug Patent Expirations in September 2012

Drug Patent Expirations for September 2012

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
GEODON
Pfizer Inc
ziprasidone hydrochloride
5,312,925
Sep 1, 2012

GEODON
Pfizer
ziprasidone hydrochloride
5,312,925
Sep 1, 2012

BESIVANCE
Ba…